Covid Treatments

Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics, LP have announced preliminary results from Ridgeback’s Phase 2a randomized, double-blind, placebo-controlled trial to evaluate the safety,…

View Post

Latest News
Let’s Talk Health
Spotlight

CSIR And Mylan Announce Partnership To Identify Advanced Therapeutic Options For Management Of COVID – 19

September 23, 2020 20:56
Healthwire Bureau

India’s premier research organization, the council of Scientific & Industrial Research (CSIR) today announced its partnership with India-based subsidiary of leading global pharmaceutical company Mylan Laboratories Limited. This partnership is…

View Post

Menu

Covid Treatments

Phase 2a Trial Of COVID-19 Therapeutic Molnupiravir Show Promising Results

CSIR And Mylan Announce Partnership To Identify Advanced Therapeutic Options For Management Of COVID – 19

Hearing Loss Is an Independent Risk Factor for Parkinson’s Disease: Jama Study Reveals

Breastfeeding Linked to Lower Rates of Postpartum Depression: Study Finds

Consuming High Levels of Omega-3, Omega-6 May Keep Cancer at Bay: Study Reveals

Effective Pain Management Approaches to Enhance Quality of Life

Chhatt Songs’ Singer Sharda Sinha Succumbs To Blood Poisoning Complication: Know All About It

No Chhath Puja at Yamuna Banks This Time As Delhi HC Refuses Permission Over Pollution, Health Concerns

Vitamin K2 Supplementation Effective In Reducing Nocturnal Leg Cramps In Older Adults: Study Shows

Diwali Firecracker Pollution: Should India Prepare For The Worst AQI Levels?